Tag: weight loss drugs
-
Exclusive: Fears over teenagers’ easy access to weight-loss drugs
Introduction: A growing concern Heavily marketed online, weight-loss drugs have become more accessible than ever. A recent investigation by Extra.ie reveals a troubling trend: teenagers are increasingly referred to medical professionals after obtaining these medications through online retailers. While adults may seek help for weight management, the ease with which minors appear to be purchasing…
-
Could Ozempic and Wegovy Cut Cancer Death Risk? Emerging Study Sparks Hope and Caution
New findings spark hope for GLP-1 drugs Recent research points to a surprising potential benefit of GLP-1 receptor agonists — the same class that includes weight‑loss medications Ozempic and Wegovy. A growing body of observational data suggests these drugs may be associated with improved cancer survival, particularly in colon cancer. While the results are intriguing,…
-
Could Ozempic and Wegovy Cut Colon Cancer Mortality? New Study Sparks Hope
Surprising findings from a new study In recent months, researchers have turned their attention to whether GLP-1 receptor agonists—drugs best known for aiding weight loss—might also influence cancer outcomes. Ozempic (semaglutide) and Wegovy (semaglutide for chronic weight management) belong to this class. A fresh analysis indicates that users of these medications could experience a meaningful…
-
UK Crime Gangs Turn to Branded Weight-Loss Drugs, Blurring Lines With Legitimate Medicine
Growing Threat: Criminals Are Manufacturing Branded Weight-Loss Drugs UK authorities have raised alarms that organised crime gangs are now producing their own branded weight-loss drugs. The trend, described by the Medicines and Healthcare products Regulatory Agency (MHRA) as a significant threat, involves illicit labs creating pills and liquids that look like legitimate medicines and are…
-
UK crime gangs shift to branded weight-loss drugs, posing public health risk
In a disturbing development for public health, UK authorities say organised crime gangs are moving into the manufacture of branded weight-loss drugs that closely resemble legitimate medicines. The move, described by the Medicines and Healthcare products Regulatory Agency (MHRA) as a growing threat, combines counterfeit chemistry with sophisticated branding to lure unsuspecting consumers. Officials warn…
-
UK Crime Gangs Move Into Branded Weight-Loss Drugs, Raising Public Health Alarm
Overview: A growing threat to public health Authorities in the United Kingdom have issued a stark warning: organised crime groups are increasingly manufacturing their own branded weight-loss drugs and distributing them as if they were legitimate medicines. The emergence of this homegrown illicit supply chain raises serious concerns about safety, efficacy and the broader risks…
-
Uncommon Knowledge: Trump’s Obesity Fix — SNAP Bans and Subsidized Drugs
Overview: A bold approach to obesity policy In recent policy circles, the term “obesity fix” has been associated with a mix of regulatory tightening and targeted subsidies. Proponents argue that aligning federal assistance programs with contemporary medical options could reduce obesity rates and related health costs. Critics fear such measures may overstep economic and civil…
-
Trump Administration Reaches Deals to Lower GLP-1 Weight Loss Drug Prices for Medicare Patients
The Trump administration announced a set of price-lowering agreements on Thursday with two of the world’s leading pharmaceutical companies, Novo Nordisk and Eli Lilly. The deals target GLP-1 receptor agonists—drugs widely prescribed for weight management and diabetes—that have faced scrutiny for their rising costs in recent years. By negotiating rebates and price caps, officials say…
-
Ozempic Sober: What GLP-1 Medications Could Mean for Alcohol Intoxication
What “Ozempic sober” means Recent research has sparked discussion about a possible new effect of GLP-1 receptor agonists, a class of drugs that includes Ozempic (semaglutide). The term “Ozempic sober” has surfaced in media coverage to describe a potential change in how the body processes and experiences alcohol while on these medications. Early signals from…
-
Unusual PET-CT Scan Patterns Linked to GLP-1 Weight-Loss Drugs
Overview: A new imaging wrinkle around popular GLP-1 medications GLP-1 receptor agonists, a class of drugs that has surged in popularity for weight loss and type 2 diabetes management, are facing fresh scrutiny. While these medications—sold under names like Ozempic, Wegovy, and Mounjaro—continue to help many shed pounds, doctors are now noting unfamiliar patterns on…